Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for RVMD

Stock Name	Revolution Medicines Inc
Ticker	RVMD(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US76155X1000
LEI	549300JU3X0LBCQ65892

Show aggregate RVMD holdings

News associated with RVMD

Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 14:49:56
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 12:32:21
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 10:58:14
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 10:14:12
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 08:20:54
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-11 20:38:25
Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes: The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25 ) are up +0.64%, and September E-mini Nasdaq futures... - 2025-09-11 20:20:22
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 19:48:54
Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes: The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25 ) are up +0.64%, and September E-mini Nasdaq futures... - 2025-09-11 14:56:29
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 14:56:29
Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes: The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25 ) are up +0.64%, and September E-mini Nasdaq futures... - 2025-09-11 14:31:03
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 14:31:02
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 12:55:25
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 12:50:08
Revolution Medicines (NASDAQ:RVMD) Earns Buy Rating from Analysts at Truist Financial: Truist Financial assumed coverage on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research note issued to investors on Friday morning, MarketBeat reports. The brokerage issued a buy rating and a $99.00 price target on the stock. RVMD has been the topic of a number of other research reports. Piper Sandler began coverage […] - 2025-09-08 02:04:55
Revolution Medicines (NASDAQ:RVMD) Now Covered by Analysts at Lifesci Capital: Investment analysts at Lifesci Capital began coverage on shares of Revolution Medicines (NASDAQ:RVMD – Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $80.00 price target on the stock. Lifesci Capital’s price target would indicate a potential upside of […] - 2025-08-20 02:24:56
Charles Schwab Investment Management Inc. Sells 646 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD): Charles Schwab Investment Management Inc. decreased its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 0.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,930,468 shares of the company’s stock after selling 646 shares during the quarter. Charles Schwab Investment […] - 2025-08-15 05:09:02
KLP Kapitalforvaltning AS Raises Stake in Revolution Medicines, Inc. (NASDAQ:RVMD): KLP Kapitalforvaltning AS grew its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 17.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,604 shares of the company’s stock after purchasing an additional 4,100 shares during the […] - 2025-07-29 06:16:53
Xponance Inc. Buys 810 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD): Xponance Inc. increased its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 6.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,937 shares of the company’s stock after buying an additional 810 shares during the period. Xponance Inc.’s holdings […] - 2025-07-18 05:01:08
Revolution Medicines, Inc. (NASDAQ:RVMD) Position Trimmed by Allspring Global Investments Holdings LLC: Allspring Global Investments Holdings LLC lowered its stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 38.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,992 shares of the company’s stock after selling 22,751 shares during the quarter. Allspring Global Investments […] - 2025-07-09 04:42:15
Mirae Asset Global Investments Co. Ltd. Buys 615 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD): Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 11.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 6,221 shares of the company’s stock after acquiring an additional 615 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in […] - 2025-07-07 04:41:58
Guggenheim Reiterates Buy Rating for Revolution Medicines (NASDAQ:RVMD): Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Guggenheim in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $80.00 price target on the stock. Guggenheim’s target price points to a potential upside of 113.45% from the stock’s current price. Several other […] - 2025-06-27 02:54:43
Revolution Medicines (NASDAQ:RVMD) Earns “Buy” Rating from Needham & Company LLC: Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $57.00 target price on the stock. Needham & Company LLC’s price target would indicate a potential upside of 48.40% from the company’s […] - 2025-06-26 03:13:04
Harbor Capital Advisors Inc. Takes Position in Revolution Medicines, Inc. (NASDAQ:RVMD): Harbor Capital Advisors Inc. acquired a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 35,417 shares of the company’s stock, valued at approximately $1,252,000. A number of other hedge funds also recently made […] - 2025-06-13 05:20:59
How The Pieces Add Up: SCHK Headed For $32: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-05 07:23:06
Analysts Set Revolution Medicines, Inc. (NASDAQ:RVMD) Price Target at $67.08: Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have been given a consensus rating of “Buy” by the twelve ratings firms that are covering the stock, MarketBeat.com reports. Twelve research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have updated their coverage on […] - 2025-06-04 02:36:53
Financial Contrast: Revolution Medicines (NASDAQ:RVMD) & Fate Therapeutics (NASDAQ:FATE): Fate Therapeutics (NASDAQ:FATE – Get Free Report) and Revolution Medicines (NASDAQ:RVMD – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation. Volatility & Risk Fate Therapeutics has a beta […] - 2025-05-28 02:34:49
Revolution Medicines, Inc. (NASDAQ:RVMD) Shares Bought by Envestnet Asset Management Inc.: Envestnet Asset Management Inc. raised its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 21.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 11,425 shares of the company’s stock after buying an additional 2,041 shares during the period. Envestnet Asset Management Inc.’s holdings in Revolution Medicines were worth $500,000 as […] - 2025-05-05 04:36:57
CANADA LIFE ASSURANCE Co Acquires 545 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD): CANADA LIFE ASSURANCE Co lifted its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 5.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,398 shares of the company’s stock after purchasing an additional 545 shares during the […] - 2025-04-30 05:48:55
Wedbush Reaffirms Outperform Rating for Revolution Medicines (NASDAQ:RVMD): Wedbush reaffirmed their outperform rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research report report published on Monday,Benzinga reports. They currently have a $67.00 target price on the stock. Other equities analysts have also issued research reports about the stock. UBS Group lifted their price target on shares of Revolution Medicines […] - 2025-04-29 04:42:49

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) RVMD holdings

Date	Number of RVMD Shares Held	Base Market Value of RVMD Shares	Local Market Value of RVMD Shares	Change in RVMD Shares Held	Change in RVMD Base Value	Current Price per RVMD Share Held	Previous Price per RVMD Share Held
2025-11-11 (Tuesday)	121,516	USD 7,786,745	USD 7,786,745	0	USD 164,046	USD 64.08	USD 62.73
2025-11-10 (Monday)	121,516	USD 7,622,699	USD 7,622,699	310	USD 227,921	USD 62.73	USD 61.01
2025-11-07 (Friday)	121,206	USD 7,394,778	USD 7,394,778	0	USD -44,846	USD 61.01	USD 61.38
2025-11-06 (Thursday)	121,206	USD 7,439,624	USD 7,439,624	310	USD 265,655	USD 61.38	USD 59.34
2025-11-05 (Wednesday)	120,896	USD 7,173,969	USD 7,173,969	0	USD 93,090	USD 59.34	USD 58.57
2025-11-04 (Tuesday)	120,896	USD 7,080,879	USD 7,080,879	312	USD -73,370	USD 58.57	USD 59.33
2025-11-03 (Monday)	120,584	USD 7,154,249	USD 7,154,249	0	USD 59,086	USD 59.33	USD 58.84
2025-10-31 (Friday)	120,584	USD 7,095,163	USD 7,095,163	0	USD -3,617	USD 58.84	USD 58.87
2025-10-30 (Thursday)	120,584	USD 7,098,780	USD 7,098,780	1,560	USD 193,008	USD 58.87	USD 58.02
2025-10-29 (Wednesday)	119,024	USD 6,905,772	USD 6,905,772	1,251	USD 54,917	USD 58.02	USD 58.17
2025-10-28 (Tuesday)	117,773	USD 6,850,855	USD 6,850,855	0	USD 21,199	USD 58.17	USD 57.99
2025-10-27 (Monday)	117,773	USD 6,829,656	USD 6,829,656	0	USD 413,383	USD 57.99	USD 54.48

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RVMD by Blackrock for IE00BDZVHG35

Show aggregate share trades of RVMD

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 310 63.130 61.500 61.663 USD 19,116 43.66
2025-11-06 BUY 310 63.150 59.400 59.775 USD 18,530 43.47
2025-11-04 BUY 312 59.680 57.740 57.934 USD 18,075 43.30
2025-10-30 BUY 1,560 60.080 57.570 57.821 USD 90,201 43.04
2025-10-29 BUY 1,251 58.020 58.850 58.767 USD 73,518 42.95
2025-10-22 SELL -1,240 52.980 54.490 54.339 USD -67,380 42.59 Loss of -14,565 on sale
2025-10-20 BUY 620 54.010 55.280 55.153 USD 34,195 42.46
2025-10-17 BUY 1,549 54.100 56.150 55.945 USD 86,659 42.39
2025-10-15 BUY 2,472 49.560 49.830 49.803 USD 123,113 42.35
2025-10-03 BUY 2,149 46.710 47.600 47.511 USD 102,101 42.29
2025-10-02 BUY 307 45.700 46.440 46.366 USD 14,234 42.27
2025-09-30 BUY 614 46.700 46.805 46.795 USD 28,732 42.23
2025-09-26 BUY 614 43.920 44.020 44.010 USD 27,022 42.19
2025-09-25 BUY 614 42.510 43.590 43.482 USD 26,698 42.19
2025-09-18 BUY 321 45.220 45.360 45.346 USD 14,556 42.17
2025-09-17 BUY 966 43.810 45.305 45.156 USD 43,620 42.16
2025-07-17 SELL -644 39.050 39.110 39.104 USD -25,183 42.21 Profit of 2,002 on sale
2025-07-16 BUY 1,073 38.400 39.060 38.994 USD 41,841 42.24
2025-07-11 SELL -2,552 38.020 38.470 38.425 USD -98,061 42.32 Profit of 9,940 on sale
2025-07-02 BUY 17,545 37.190 37.900 37.829 USD 663,710 42.44
2025-06-25 BUY 636 38.410 40.235 40.053 USD 25,473 42.58
2025-06-20 BUY 2,876 39.660 40.250 40.191 USD 115,589 42.64
2025-06-11 BUY 618 40.790 42.400 42.239 USD 26,104 42.76
2025-06-10 BUY 618 41.980 42.290 42.259 USD 26,116 42.77
2025-06-04 SELL -309 40.380 41.210 41.127 USD -12,708 42.84 Profit of 529 on sale
2025-04-23 BUY 309 37.440 39.140 38.970 USD 12,042 43.83
2025-04-10 SELL -2,472 33.670 34.300 34.237 USD -84,634 44.61 Profit of 25,635 on sale
2025-04-08 SELL -309 31.130 33.210 33.002 USD -10,198 44.87 Profit of 3,668 on sale
2025-04-07 SELL -309 31.400 32.070 32.003 USD -9,889 45.03 Profit of 4,025 on sale
2025-04-04 SELL -1,545 31.320 33.025 32.855 USD -50,760 45.19 Profit of 19,057 on sale
2025-04-01 BUY 2,690 33.620 36.050 35.807 USD 96,321 45.46
2025-03-31 SELL -912 35.360 36.770 36.629 USD -33,406 45.58 Profit of 8,163 on sale
2025-03-21 BUY 12,259 38.110 38.810 38.740 USD 474,914 46.16
2025-03-14 SELL -4,208 39.120 39.735 39.674 USD -166,946 46.69 Profit of 29,513 on sale
2025-03-07 SELL -526 39.210 39.850 39.786 USD -20,927 47.30 Profit of 3,951 on sale
2025-03-04 SELL -263 37.960 38.459 38.409 USD -10,102 47.70 Profit of 2,442 on sale
2025-02-25 BUY 526 41.340 42.220 42.132 USD 22,161 48.36
2025-02-19 SELL -263 42.340 42.370 42.367 USD -11,143 48.85 Profit of 1,704 on sale
2025-02-13 BUY 789 41.320 42.680 42.544 USD 33,567 49.47
2025-02-12 BUY 263 42.000 42.100 42.090 USD 11,070 49.62
2025-02-11 BUY 1,052 41.450 42.175 42.102 USD 44,292 49.79
2024-12-30 SELL -8,861 43.170 44.190 44.088 USD -390,664 53.20 Profit of 80,758 on sale
2024-11-18 SELL -4,305 54.240 55.950 55.779 USD -240,129 52.83 Loss of -12,709 on sale
2024-11-08 SELL -287 60.440 61.060 60.998 USD -17,506 51.82 Loss of -2,634 on sale
2024-10-21 SELL -287 47.750 50.310 50.054 USD -14,365 0.00 Loss of -14,365 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	310	63.130	61.500	61.663	USD 19,116	43.66
2025-11-06	BUY	310	63.150	59.400	59.775	USD 18,530	43.47
2025-11-04	BUY	312	59.680	57.740	57.934	USD 18,075	43.30
2025-10-30	BUY	1,560	60.080	57.570	57.821	USD 90,201	43.04
2025-10-29	BUY	1,251	58.020	58.850	58.767	USD 73,518	42.95
2025-10-22	SELL	-1,240	52.980	54.490	54.339	USD -67,380	42.59 Loss of -14,565 on sale
2025-10-20	BUY	620	54.010	55.280	55.153	USD 34,195	42.46
2025-10-17	BUY	1,549	54.100	56.150	55.945	USD 86,659	42.39
2025-10-15	BUY	2,472	49.560	49.830	49.803	USD 123,113	42.35
2025-10-03	BUY	2,149	46.710	47.600	47.511	USD 102,101	42.29
2025-10-02	BUY	307	45.700	46.440	46.366	USD 14,234	42.27
2025-09-30	BUY	614	46.700	46.805	46.795	USD 28,732	42.23
2025-09-26	BUY	614	43.920	44.020	44.010	USD 27,022	42.19
2025-09-25	BUY	614	42.510	43.590	43.482	USD 26,698	42.19
2025-09-18	BUY	321	45.220	45.360	45.346	USD 14,556	42.17
2025-09-17	BUY	966	43.810	45.305	45.156	USD 43,620	42.16
2025-07-17	SELL	-644	39.050	39.110	39.104	USD -25,183	42.21 Profit of 2,002 on sale
2025-07-16	BUY	1,073	38.400	39.060	38.994	USD 41,841	42.24
2025-07-11	SELL	-2,552	38.020	38.470	38.425	USD -98,061	42.32 Profit of 9,940 on sale
2025-07-02	BUY	17,545	37.190	37.900	37.829	USD 663,710	42.44
2025-06-25	BUY	636	38.410	40.235	40.053	USD 25,473	42.58
2025-06-20	BUY	2,876	39.660	40.250	40.191	USD 115,589	42.64
2025-06-11	BUY	618	40.790	42.400	42.239	USD 26,104	42.76
2025-06-10	BUY	618	41.980	42.290	42.259	USD 26,116	42.77
2025-06-04	SELL	-309	40.380	41.210	41.127	USD -12,708	42.84 Profit of 529 on sale
2025-04-23	BUY	309	37.440	39.140	38.970	USD 12,042	43.83
2025-04-10	SELL	-2,472	33.670	34.300	34.237	USD -84,634	44.61 Profit of 25,635 on sale
2025-04-08	SELL	-309	31.130	33.210	33.002	USD -10,198	44.87 Profit of 3,668 on sale
2025-04-07	SELL	-309	31.400	32.070	32.003	USD -9,889	45.03 Profit of 4,025 on sale
2025-04-04	SELL	-1,545	31.320	33.025	32.855	USD -50,760	45.19 Profit of 19,057 on sale
2025-04-01	BUY	2,690	33.620	36.050	35.807	USD 96,321	45.46
2025-03-31	SELL	-912	35.360	36.770	36.629	USD -33,406	45.58 Profit of 8,163 on sale
2025-03-21	BUY	12,259	38.110	38.810	38.740	USD 474,914	46.16
2025-03-14	SELL	-4,208	39.120	39.735	39.674	USD -166,946	46.69 Profit of 29,513 on sale
2025-03-07	SELL	-526	39.210	39.850	39.786	USD -20,927	47.30 Profit of 3,951 on sale
2025-03-04	SELL	-263	37.960	38.459	38.409	USD -10,102	47.70 Profit of 2,442 on sale
2025-02-25	BUY	526	41.340	42.220	42.132	USD 22,161	48.36
2025-02-19	SELL	-263	42.340	42.370	42.367	USD -11,143	48.85 Profit of 1,704 on sale
2025-02-13	BUY	789	41.320	42.680	42.544	USD 33,567	49.47
2025-02-12	BUY	263	42.000	42.100	42.090	USD 11,070	49.62
2025-02-11	BUY	1,052	41.450	42.175	42.102	USD 44,292	49.79
2024-12-30	SELL	-8,861	43.170	44.190	44.088	USD -390,664	53.20 Profit of 80,758 on sale
2024-11-18	SELL	-4,305	54.240	55.950	55.779	USD -240,129	52.83 Loss of -12,709 on sale
2024-11-08	SELL	-287	60.440	61.060	60.998	USD -17,506	51.82 Loss of -2,634 on sale
2024-10-21	SELL	-287	47.750	50.310	50.054	USD -14,365	0.00 Loss of -14,365 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RVMD

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	300,104	2,133	700,642	42.8%
2025-09-18	367,368	0	776,112	47.3%
2025-09-17	498,443	2,812	930,445	53.6%
2025-09-16	487,968	11,217	1,103,098	44.2%
2025-09-15	430,451	1,481	597,164	72.1%
2025-09-12	914,877	19,259	1,413,203	64.7%
2025-09-11	1,199,712	0	1,892,860	63.4%
2025-09-10	312,254	0	704,839	44.3%
2025-09-09	337,745	0	502,700	67.2%
2025-09-08	467,925	43	736,533	63.5%
2025-09-05	362,986	3,745	693,897	52.3%
2025-09-04	409,971	0	620,438	66.1%
2025-09-03	398,340	5,153	704,219	56.6%
2025-09-02	611,085	2,868	1,016,011	60.1%
2025-08-29	426,121	0	720,382	59.2%
2025-08-28	417,217	0	898,421	46.4%
2025-08-27	424,587	788	778,879	54.5%
2025-08-26	407,765	24	1,042,293	39.1%
2025-08-25	400,142	4,158	655,516	61.0%
2025-08-22	155,195	1,002	380,934	40.7%
2025-08-21	257,981	14,169	836,568	30.8%
2025-08-20	271,751	5,703	470,010	57.8%
2025-08-19	484,281	1,314	813,560	59.5%
2025-08-18	493,360	1,074	874,639	56.4%
2025-08-15	178,552	1,734	472,936	37.8%
2025-08-14	288,131	0	1,269,683	22.7%
2025-08-13	319,783	258	1,031,313	31.0%
2025-08-12	442,508	754	856,817	51.6%
2025-08-11	343,563	971	552,257	62.2%
2025-08-08	572,808	1,595	1,493,622	38.4%
2025-08-07	688,763	50	1,866,499	36.9%
2025-08-06	211,709	3,085	580,071	36.5%
2025-08-05	325,276	4,640	553,712	58.7%
2025-08-04	135,754	0	309,743	43.8%
2025-08-01	150,496	802	330,169	45.6%
2025-07-31	238,480	7	496,842	48.0%
2025-07-30	380,135	0	648,252	58.6%
2025-07-29	253,284	0	548,004	46.2%
2025-07-28	316,127	2,117	530,889	59.5%
2025-07-25	309,817	0	492,061	63.0%
2025-07-24	251,431	6	464,409	54.1%
2025-07-23	227,030	726	470,901	48.2%
2025-07-22	255,660	0	392,884	65.1%
2025-07-21	334,580	0	634,846	52.7%
2025-07-18	378,255	96	652,885	57.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE